Investigating MPXV Viral Clearance in Mpox Cases and Secondary Attack Rate in Contacts
NCT07267390 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 550
Last updated 2026-05-01
Summary
The MOVIE-TRACE project includes two complementary observational studies designed to improve the understanding of Mpox virus infection and its transmission within affected communities. The MOVIE study aims to describe the dynamics of viral clearance in patients with confirmed Mpox. It measures how the viral load changes over time in different biological samples to inform decisions about patient management and isolation guidelines. The TRACE study focuses on understanding how mpox spreads from confirmed cases to their contacts. It will estimate the Secondary Attack Rate (SAR) and identify factors associated with transmission risk. The results will help guide public health strategies for contact tracing, vaccination, and outbreak control.
Conditions
- Mpox (Monkeypox)
Sponsors & Collaborators
-
University of Kinshasa
collaborator OTHER -
London School of Hygiene and Tropical Medicine
collaborator OTHER -
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
lead OTHER
Principal Investigators
-
Oriol Mitjà, Professor · Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-10-31
- Primary Completion
- 2026-02-27
- Completion
- 2026-02-27
Countries
- Democratic Republic of the Congo
Study Locations
More Related Trials
-
Monkeypox ASymptomatic Shedding: Evaluation by Self-Sampling MPX-ASSESS
NCT05443867 ·Status: COMPLETED
-
Break-through Infection Following Mpox vaccinatIon
NCT05522296 ·Status: COMPLETED
-
Viral Clearance and Epidemiological Characteristics in Patients With Monkeypox
NCT05476744 ·Status: COMPLETED
-
Clinical and Biological Aspects of the MONKEYPOX Disease
NCT05627713 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Acceptability of a Monkeypox Curriculum for Disproportionately Impacted Communities
NCT05651581 ·Status: COMPLETED ·Phase: NA
-
A One Health Study of Monkeypox Human Infection
NCT05058898 ·Status: ACTIVE_NOT_RECRUITING
-
Clinical Prognostic Score to Predict Relapse in VL
NCT05602610 ·Status: RECRUITING
-
Malaria Clinical Trials Center General Screening
NCT02119312 ·Status: COMPLETED
-
Miltefosine/Paromomycin Phase III Trial for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern Africa
NCT03129646 ·Status: COMPLETED ·Phase: PHASE3
-
Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria
NCT07235020 ·Status: COMPLETED ·Phase: PHASE2
-
Low Antimonial Dosage in American Mucosal Leishmaniasis
NCT01301937 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Malaria Infection Diagnosed by Polymerase Chain Reaction (PCR) as a Means of Evaluating Pre-erythrocytic Candidate Malaria Vaccines
NCT00121823 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Immunogenicity in Age De-Escalation of PfSPZ Vaccine in Tanzanian Adults, Children, and Infants
NCT02613520 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety and Efficacy Study of ChAd63/MVA METRAP + RTS,S
NCT01883609 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Controlled Human Plasmodium Vivax Infection
NCT03377296 ·Status: COMPLETED ·Phase: NA
-
FocaL Mass Drug Administration for Vivax Malaria Elimination
NCT05690841 ·Status: RECRUITING ·Phase: PHASE3
-
A Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease.
NCT06632600 ·Status: RECRUITING ·Phase: PHASE2
-
Assessment of Safety Profile of MVA-BN Vaccine in the PALM-007 Study in DRC
NCT05734508 ·Status: COMPLETED ·Phase: PHASE4
-
Phase Ib Trial of Two Virosome Formulated Malaria Vaccine Components (PEV 301, PEV 302) in Tanzania
NCT00513669 ·Status: COMPLETED ·Phase: PHASE1
-
WR 279,396 for the Treatment of Cutaneous Leishmaniasis
NCT01988909 ·Status: COMPLETED ·Phase: PHASE2
-
LXE408 for Treatment of Visceral Leishmaniasis in Ethiopia, a Proof of Concept Study
NCT05957978 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Acoziborole (SCYX-7158) in Patients With Human African Trypanosomiasis Due to T.b. Gambiense
NCT03087955 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Phase I/IIa Sporozoite Challenge Study to Assess the Efficacy of Candidate Combination Malaria Vaccine Approaches Using the ChAd63 and MVA Vectors Encoding the Antigens ME-TRAP, CS and AMA1
NCT01739036 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Bedaquiline Enhanced Post ExpOsure Prophylaxis for Leprosy (Phase 2)
NCT05406479 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety and Efficacy Study of Concomitant Administration of ChAd63/MVA ME-TRAP + RTS,S
NCT02252640 ·Status: COMPLETED ·Phase: PHASE1/PHASE2